PURPOSE: When faced with a significant recruitment challenge for three nationwide psychoeducational trials targeting prostate and breast cancer patients, the Cancer Information Service Research Consortium initiated outreach efforts to increase accrual. Recruitment is reported by major outreach strategy to inform the use of similar campaigns, either as primary recruitment efforts or to supplement "in-reach" recruitment within oncology settings. METHODS: During a 33-month period, recruitment was tracked from the National Cancer Institute's Cancer Information Service (CIS), the American Cancer Society (ACS), Dr. Susan Love Research Foundation's Love/Avon Army of Women (AOW), Internet advertising, press releases, radio/television interviews, recruitment materials in community venues, and outreach to churches and cancer support organizations. RESULTS: Across projects, the majority (89 %) of recruited participants (N = 2,134) was obtained from the CIS (n = 901, 19 months of recruitment), AOW (n = 869, 18 months), and ACS (n = 123, 12 months). Other efforts showed minimal gain in recruitment. CONCLUSIONS: Cancer information programs (e.g., CIS and ACS) and registries of individuals willing to participate in cancer-related research (e.g., AOW) can represent exceptional resources for outreach recruitment of cancer patients, especially when the eligibility criteria are highly restrictive. However, these resources do not yield samples representative of the larger population of adults diagnosed with cancer, and conclusions from such trials must be tempered accordingly. IMPLICATIONS FOR CANCER SURVIVORS: Inadequate recruitment to randomized controlled trials limits the creation of useful interventions for cancer survivors. By enrolling in cancer registries and taking part in research, cancer survivors can contribute to the development of effective resources for the survivor population.
PURPOSE: When faced with a significant recruitment challenge for three nationwide psychoeducational trials targeting prostate and breast cancerpatients, the Cancer Information Service Research Consortium initiated outreach efforts to increase accrual. Recruitment is reported by major outreach strategy to inform the use of similar campaigns, either as primary recruitment efforts or to supplement "in-reach" recruitment within oncology settings. METHODS: During a 33-month period, recruitment was tracked from the National Cancer Institute's Cancer Information Service (CIS), the American Cancer Society (ACS), Dr. Susan Love Research Foundation's Love/Avon Army of Women (AOW), Internet advertising, press releases, radio/television interviews, recruitment materials in community venues, and outreach to churches and cancer support organizations. RESULTS: Across projects, the majority (89 %) of recruited participants (N = 2,134) was obtained from the CIS (n = 901, 19 months of recruitment), AOW (n = 869, 18 months), and ACS (n = 123, 12 months). Other efforts showed minimal gain in recruitment. CONCLUSIONS:Cancer information programs (e.g., CIS and ACS) and registries of individuals willing to participate in cancer-related research (e.g., AOW) can represent exceptional resources for outreach recruitment of cancerpatients, especially when the eligibility criteria are highly restrictive. However, these resources do not yield samples representative of the larger population of adults diagnosed with cancer, and conclusions from such trials must be tempered accordingly. IMPLICATIONS FOR CANCER SURVIVORS: Inadequate recruitment to randomized controlled trials limits the creation of useful interventions for cancer survivors. By enrolling in cancer registries and taking part in research, cancer survivors can contribute to the development of effective resources for the survivor population.
Authors: Kuang-Yi Wen; Suzanne M Miller; Annette L Stanton; Linda Fleisher; Marion E Morra; Alexandra Jorge; Michael A Diefenbach; Mary E Ropka; Alfred C Marcus Journal: Patient Educ Couns Date: 2012-07-07
Authors: P J Goodwin; M Leszcz; G Quirt; J Koopmans; A Arnold; E Dohan; M Hundleby; H M Chochinov; M Navarro Journal: J Clin Epidemiol Date: 2000-01 Impact factor: 6.437
Authors: D B Stoy; R C Curtis; K S Dameworth; A A Dowdy; J Hegland; J A Levin; B G Sousoulas Journal: J Natl Med Assoc Date: 1995-04 Impact factor: 1.798
Authors: Sharon R Sears; Annette L Stanton; Lorna Kwan; Janice L Krupnick; Julia H Rowland; Beth E Meyerowitz; Patricia A Ganz Journal: Cancer Epidemiol Biomarkers Prev Date: 2003-10 Impact factor: 4.254
Authors: N R Boyd; C Sutton; C T Orleans; M W McClatchey; R Bingler; L Fleisher; D Heller; S Baum; C Graves; J A Ward Journal: Prev Med Date: 1998 Sep-Oct Impact factor: 4.018
Authors: A C Marcus; M E Morra; E Bettinghaus; L A Crane; G Cutter; S Davis; B K Rimer; C Thomsen; R B Warnecke Journal: Prev Med Date: 1998 Sep-Oct Impact factor: 4.018
Authors: Electra D Paskett; Katherine W Reeves; John M McLaughlin; Mira L Katz; Ann Scheck McAlearney; Mack T Ruffin; Chanita Hughes Halbert; Cristina Merete; Faith Davis; Sarah Gehlert Journal: Contemp Clin Trials Date: 2008-07-31 Impact factor: 2.226
Authors: Michael A Diefenbach; Catherine Benedict; Suzanne M Miller; Annette L Stanton; Mary E Ropka; Kuang-Yi Wen; Linda G Fleisher; Nihal E Mohamed; Simon J Hall Journal: Transl Behav Med Date: 2018-11-21 Impact factor: 3.046
Authors: Linda Fleisher; Kuang Yi Wen; Suzanne M Miller; Michael Diefenbach; Annette L Stanton; Mary Ropka; Marion Morra; Peter C Raich Journal: Internet Interv Date: 2015-11-01
Authors: Jennifer Barsky Reese; Kristen A Sorice; Natalie M Oppenheimer; Katherine Clegg Smith; Sharon L Bober; Elissa T Bantug; Sharon C Schwartz; Laura S Porter Journal: Transl Behav Med Date: 2020-05-20 Impact factor: 3.046
Authors: Sachiko M Oshima; Sarah D Tait; Christel Rushing; Whitney Lane; Terry Hyslop; Anaeze C Offodile; Stephanie B Wheeler; S Yousuf Zafar; Rachel Greenup; Laura J Fish Journal: JCO Oncol Pract Date: 2021-02-10
Authors: Alex Molassiotis; Shelley Roberts; Hui Lin Cheng; Henry K F To; Po Shan Ko; Wang Lam; Yuk Fong Lam; Jessica Abbott; Deborah Kiefer; Jasotha Sanmugarajah; Andrea P Marshall Journal: BMC Palliat Care Date: 2018-03-20 Impact factor: 3.234